BioAesthetics

BioAesthetics

Improving reconstruction options for breast cancer patients after they undergo mastectomies.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

€0.0

round
investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
*

N/A

Convertible
Total Funding000k
More about BioAesthetics
Made with AI
Edit

BioAesthetics is a pioneering company in the field of regenerative medicine, specializing in biologically derived collagen grafts for nipple reconstruction post-mastectomy. The company primarily serves breast cancer survivors who have undergone mastectomies and are seeking realistic and natural-looking nipple reconstruction. Operating in the healthcare and biotechnology market, BioAesthetics employs a business-to-business (B2B) model, partnering with hospitals, clinics, and plastic surgeons to distribute its innovative NAC (Nipple-Areolar Complex) Graft. The company generates revenue through the sale of these grafts, which are designed to integrate with the patient's body, becoming a living structure. BioAesthetics leverages cutting-edge science and commercialization strategies to bring its products to market, aiming to improve the quality of life for breast cancer survivors.

Keywords: regenerative medicine, collagen grafts, nipple reconstruction, post-mastectomy, breast cancer survivors, healthcare, biotechnology, NAC Graft, B2B model, plastic surgery.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo